These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4427626)

  • 21. [Ischemic renal disease: revascularization or conservative treatment?].
    Rodríguez Jornet A; Ibeas J; Ribera L; Real J; Perendreu J; Falcó J; Vallespín J; Allegué N; Giménez Gaibar A; García García M
    Nefrologia; 2005; 25(3):258-68. PubMed ID: 16053007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Digoxin-like substance in blood and hypertension in dialysed patients with chronic renal failure].
    Lapiński M; Wocial B; Januszewicz A; Stepniakowski K; Januszewicz W
    Pol Tyg Lek; 1991 Aug 26-Sep 2; 46(35-36):655-4. PubMed ID: 1845688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of 12 years' treatment of chronic renal failure by dialysis and transplantation.
    Price JD; Ashby KM; Reeve CE
    Can Med Assoc J; 1978 Feb; 118(3):263-6. PubMed ID: 343897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Secondary cystic changes in the kidneys in chronic kidney failure].
    Todorov V; Lalev I; Monov A; Penkova S
    Vutr Boles; 1989; 28(2):67-72. PubMed ID: 2669341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effects of long-term administration of an oral adsorbent in patients with chronic renal failure: two-year study.
    Takahashi N; Kawaguchi T; Suzuki T
    Int J Urol; 2005 Jan; 12(1):7-11. PubMed ID: 15661048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Causes of chronic renal failure among Iranian hemodialysis patients.
    Malekmakan L; Haghpanah S; Pakfetrat M; Malekmakan A; Khajehdehi P
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):501-4. PubMed ID: 19414964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diazoxide administered to control hypertension in patients on extracorporeal hemodialysis (author's transl)].
    Prejac M; Jeren B; Crnjaković J
    Lijec Vjesn; 1976 Jul; 98(7):385-90. PubMed ID: 979533
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of antihypertensive drugs in the therapy of patients on regular dialysis treatment.
    Sulková S; Válek A
    Kidney Int Suppl; 1988 Sep; 25():S198-200. PubMed ID: 3184612
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chronic renal failure and arterial hypertension with "favourable" and "unfavourable" response to haemodialysis--haemodynamic changes in patients (author's transl)].
    Tomásek R; Horký K; Ort J; Lachmanová J; Straková M; Benes R
    Cas Lek Cesk; 1980 Aug; 119(33-34):897-902. PubMed ID: 7438159
    [No Abstract]   [Full Text] [Related]  

  • 30. Discontinuation of chronic haemodialysis after control of arterial hypertension; long term follow-up.
    Wauters JP; Brunner HR
    Proc Eur Dial Transplant Assoc; 1983; 19():182-7. PubMed ID: 6878232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is hypertension a mortality risk factor in dialysis?
    Duranti E; Imperiali P; Sasdelli M
    Kidney Int Suppl; 1996 Jun; 55():S173-4. PubMed ID: 8743547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Some decisive factors in the onset and evelopment of cardiac insufficiency in patients with chronic renal failure undergoing regular dialysis treatment].
    Tomásek R; Lisý Z; Lachmanová J; Knotková V; Turek T
    Cas Lek Cesk; 1977 Mar; 116(10):301-5. PubMed ID: 858155
    [No Abstract]   [Full Text] [Related]  

  • 33. [A familial history of hypertension is associated with the development of hypertension and nephroangiosclerosis in patients with glomerulonephritis caused by mesangial IgA deposits].
    Boulahrouz R; Autuly V; Charasse C; Le Cacheux P; Ang KS; Ramee MP; Simon P
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1065-8. PubMed ID: 8949380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Central hemodynamic indices of patients with chronic kidney failure treated by hemodialysis].
    Pevzner AS; Fedorov VV; Voronina EO; D'iachuk MM; Konstantinov IuV
    Vrach Delo; 1989 Jan; (1):14-6. PubMed ID: 2718433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The natural history of diabetic renal disease. A follow-up study of a series of renal biopsies.
    Watkins PJ; Blainey JD; Brewer DB; Fitzgerald MG; Malins JM; O'Sullivan DJ; Pinto JA
    Q J Med; 1972 Oct; 41(164):437-56. PubMed ID: 4564622
    [No Abstract]   [Full Text] [Related]  

  • 36. Risk factors of renal failure progression two years prior to dialysis.
    Mazouz H; Kacso I; Ghazali A; El Esper N; Moriniere P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
    Clin Nephrol; 1999 Jun; 51(6):355-66. PubMed ID: 10404696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteinuria in benign nephrosclerosis.
    Morduchowicz G; Boner G; Ben-Bassat M; Rosenfeld JB
    Arch Intern Med; 1986 Aug; 146(8):1513-6. PubMed ID: 3729631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleeping disorders in patients with end-stage renal disease and chronic kidney disease.
    De Santo RM; Bartiromo M; Cesare MC; De Santo NG; Cirillo M
    J Ren Nutr; 2006 Jul; 16(3):224-8. PubMed ID: 16825024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two years' experience with the chronic intermittent haemodialysis program (CHIHP) in patients with chronic renal failure.
    Erben J; Krch V; Macek J; Kvasnicka J; Bartos V; Bastecký J; David I
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1969; 12(5):571-8. PubMed ID: 5267594
    [No Abstract]   [Full Text] [Related]  

  • 40. [Is conventional hemodialysis an appropriate dialysis?].
    Andrés E
    Nefrologia; 2005; 25 Suppl 2():10-4. PubMed ID: 16050395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.